RenovoRx (RNXT) Market Capitalization (2021 - 2026)

RenovoRx has disclosed Market Capitalization across 6 years of filings, most recently posting $44.2 million for Q2 2026.

• In Q2 2026, Market Capitalization fell 8.59% year-over-year to $44.2 million; the TTM figure through Jun 2026 stood at $44.2 million (down 8.59% YoY), while the FY2025 annual figure was $30.8 million, down 0.8% from the prior year.
• Market Capitalization came in at $44.2 million for Q2 2026 at RenovoRx, down from $45.5 million in the prior quarter.
• In the past five years, Market Capitalization ranged from a high of $48.4 million in Q2 2025 to a low of $14.2 million in Q3 2023.
• Average Market Capitalization over 5 years is $29.8 million, with a median of $26.8 million recorded in 2022.
• Year-over-year, Market Capitalization plunged 46.01% in 2022 and jumped 82.95% in 2025.
• Over 5 years, Market Capitalization stood at $21.4 million in 2022, then rose by 14.54% to $24.5 million in 2023, then increased by 26.61% to $31.0 million in 2024, then slipped by 0.8% to $30.8 million in 2025, then soared by 43.78% to $44.2 million in 2026.
• Per Business Quant data, the three most recent Market Capitalization figures were $44.2 million in Q2 2026, $45.5 million in Q1 2026, and $30.8 million in Q4 2025.